Medtronic

Traded on the St. Petersburg Stock Exchange
Medtronic plc is an American Irish-domiciled medical device company. The company consists of six main business units (heart rhythm disorders, neuromodulation, spine surgery, diabetes, cardiac surgery, surgical navigation technology), which develop and manufacture instruments and methods to treat many chronic diseases, including heart failure, Parkinson's disease, chronic pain and diabetes.
Medtronic stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Medtronic balance sheet

Report period2019 2020 2021 20222023 Q2 24
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Medtronic cash flows

Report period2019 2020 2021 20222023 Q2 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Medtronic multipliers

Report period2019 2020 2021 20222023 Q2 24 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Medtronic profitability

Report period2019 2020 2021 20222023 Q2 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Medtronic assets
Medtronic cash flows
Medtronic dividends
3.33%

Medtronic dividend policy

The company pays dividends quarterly

Medtronic shares

TickerNameTypeNominal valueISINPrice
MDT:USMedtronic plc.Common share-IE00BTN1Y115$89.99
Medtronic news
21.06.2022
Medtronic has received FDA approval for the LigaPAS 2.0 medical device. The device is used for ligament augmentation in spine surgery.
Source: {source} pictogram news.medtronic.com
Pictogram next
26.05.2022
Medtronic and DaVita plan to form a joint venture to manufacture medical devices for kidney care. Medtronic will contribute the Renal Care Solutions business and related product portfolio, as well as global manufacturing R&D teams and facilities. The partners will have equal stakes in the venture. The joint venture is expected to be completed next year.
Source: {source} pictogram investors.davita.com
Pictogram next
26.05.2022
The Medtronic Board of Directors announced a quarterly dividend of $0.68 per share. The last day to buy securities to receive the dividend is June 22, 2022. The annual dividend yield may reach 2.36%.
Source: {source} pictogram news.medtronic.com
Pictogram next
26.05.2022
Medtronic's GAAP net income for fiscal year 2022 was $5.062 billion, up 39.4% from $3.63 billion in the previous year. Revenue increased 5.2% to $31.686 billion from $30.117 billion a year earlier.
Source: {source} pictogram news.medtronic.com
Pictogram next
All Medtronic news
General information
Company nameMedtronic
Tags#medtech, #dividend aristocrats, #s&p500 index
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address20 ON HATCH, LOWER HATCH STREET DUBLIN L2 2 01135314381700
Mailing address20 ON HATCH, LOWER HATCH STREET DUBLIN L2 2
Websiteinvestorrelations.medtronic.com
Information disclosurewww.sec.gov